BREAKTHROUGHS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PURPOSES

Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sphere of biopharmaceuticals, giving promising progress throughout a variety of health-related and industrial programs. With its structural similarity to The natural way derived human serum albumin, OsrHSA presents a safer, more trusted substitute for therapeutic